Addy
Analyst
Evercore
Equibles does not estimate personal net worth.
About Addy
Addy is recorded as Analyst at Evercore. Addy has spoken on 2 earnings calls across 2 companies, most recently for Xenon Pharmaceuticals Inc. on May 7, 2026. Those appearances were for Xenon Pharmaceuticals Inc. (XENE) and Biomarin Pharmaceutical Inc (BMRN). The companies whose calls Addy spoke on are classified in the Healthcare sector.
Addy on recent calls
“Just on the earlier question asked on the pain assets, I just wanted to ask that, can you confirm if investors should anticipate any data this year? I believe earlier it was mentioned that maybe phase one SADNAT data might be presented.”
“I had a question on the guidance increase. The $500 million from MIPPOINC increase in guidance, can you frame that, you know, the contribution from Garafore, is that conservative relative to the $600 million revenue that generated in fiscal year 2025?”
Affiliation history
-
Evercore
Analyst
Transcript header (unverified)
Current